Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

TADALISTA 5

Description:

TADALISTA 5 is a medication manufactured by Fortune Health Care, containing the active substance Tadalafil. It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, primarily used in the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) in adult men.

Mechanism of Action:

Tadalafil works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which is involved in the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. By inhibiting PDE5, Tadalafil helps to increase the levels of cGMP, leading to smooth muscle relaxation and increased blood flow to the penis, which facilitates an erection.

Indications:

TADALISTA 5 (Tadalafil) is indicated for the treatment of:

• Erectile dysfunction (ED): It helps men achieve and maintain erections sufficient for satisfactory sexual activity.
• Benign prostatic hyperplasia (BPH): Tadalafil is also used in the management of BPH symptoms, including urinary frequency, urgency, and difficulty urinating.

Dosage and Administration:

• The recommended dosage of TADALISTA 5 is one tablet (5 mg) taken orally with water, once daily.
• It can be taken with or without food.
• The tablet should be swallowed whole, without chewing or breaking it.
• TADALISTA 5 should not be taken more than once within a 24-hour period.

Potential Side Effects:

• Common side effects of Tadalafil may include:
  • Headache
  • Flushing
  • Back pain
  • Muscle aches
  • Nasal congestion
  • Indigestion
• More serious side effects are rare but can include:
  • Priapism (prolonged erection lasting more than four hours)
  • Sudden vision or hearing loss
  • Allergic reactions

Precautions:

• TADALISTA 5 should be used with caution in individuals with certain medical conditions, such as cardiovascular disease, liver or kidney impairment, or bleeding disorders.
• It may interact with certain medications, particularly nitrates and alpha-blockers, and patients should inform their healthcare provider of all medications they are taking.
• Alcohol consumption should be limited while taking Tadalafil, as it can increase the risk of side effects.

Note:

TADALISTA 5 (Tadalafil) is an effective medication for the treatment of erectile dysfunction and benign prostatic hyperplasia. Its use should be under the supervision of a qualified healthcare professional, and patients are advised to follow their healthcare provider’s recommendations closely for optimal safety and efficacy.